MYNZ
MYNZ
NASDAQ · Biotechnology

Mainz Biomed Nv

$0.95
-0.04 (-4.51%)
As of Feb 8, 2:29 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.72M 1.76M 1.56M
Net Income -70,204 -56,960 -48,803
EPS
Profit Margin -4.1% -3.2% -3.1%
Rev Growth -1.5% +11.5% -6.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.05M 1.22M 1.09M
Total Equity 3.92M 4.09M 3.85M
D/E Ratio 0.27 0.30 0.28
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -71,856 -70,729 -65,893
Free Cash Flow -27,215 -37,098 -32,467